Do antibody CDR loops change conformation upon binding?

MAbs. 2024 Jan-Dec;16(1):2322533. doi: 10.1080/19420862.2024.2322533. Epub 2024 Mar 13.

Abstract

Antibodies have increasingly been developed as drugs with over 100 now licensed in the US or EU. During development, it is often necessary to increase or reduce the affinity of an antibody and rational attempts to do so rely on having a structure of the antibody-antigen complex often obtained by modeling. The antigen-binding site consists primarily of six loops known as complementarity-determining regions (CDRs), and an open question has been whether these loops change their conformation when they bind to an antigen. Existing surveys of antibody-antigen complex structures have only examined CDR conformational change in case studies or small-scale surveys. With an increasing number of antibodies where both free and complexed structures have been deposited in the Protein Data Bank, a large-scale survey of CDR conformational change during binding is now possible. To this end, we built a dataset, AbAgDb, that currently includes 177 antibodies with high-quality CDRs, each of which has at least one bound and one unbound structure. We analyzed the conformational change of the Cα backbone of each CDR upon binding and found that, in most cases, the CDRs (other than CDR-H3) show minimal movement, while 70.6% and 87% of CDR-H3s showed global Cα RMSD ≤ 1.0Å and ≤ 2.0Å, respectively. We also compared bound CDR conformations with the conformational space of unbound CDRs and found most of the bound conformations are included in the unbound conformational space. In future, our results will contribute to developing insights into antibodies and new methods for modeling and docking.

Keywords: CDR flexibility; CDRs; antibodies; antibody binding; antibody structure; complementarity determining regions.

MeSH terms

  • Amino Acid Sequence
  • Antigen-Antibody Complex / chemistry
  • Antigens*
  • Binding Sites, Antibody
  • Complementarity Determining Regions* / chemistry
  • Models, Molecular
  • Protein Conformation

Substances

  • Complementarity Determining Regions
  • Antigens
  • Antigen-Antibody Complex

Grants and funding

CL was part-funded by a UCL Centre for Digital Innovation AWS Scholarship; LMD was funded by an ISMB MRC iCASE Studentship (MR/R015759/1).